Pharmacokinetics and Pharmacodynamics Practice Questions

Q: An example of covalent drug-receptor interaction is:

Phenoxybenzamine binding to alpha adrenergic receptor. **Explanation:** The correct answer is **D. Phenoxybenzamine binding to alpha adrenergic receptor.** **1. Why it is correct:** Most drug-receptor interactions are reversible and involve weak bonds (ionic, hydrogen, or Van der Waals). However, **Phenoxybenzamine** is a classic example of an **irreversible, non-competitive antagonist**. It undergoes a chemical transformation to form a highly reactive ethyleniminium intermediate, which then forms a **strong covalent bond** with the alpha-adrenergic receptor. Because covalent bonds are stable and difficult to break, the blockade is long-lasting (24–48 hours) and cannot be overcome by increasing the concentration of the agonist. **2. Why the other options are incorrect:** * **A & B (Noradrenaline and Acetylcholine):** These are endogenous neurotransmitters. Physiological signaling requires rapid onset and termination; therefore, they bind via **reversible, non-covalent bonds** to allow for quick dissociation and signal termination. * **C (Prazosin):** Unlike phenoxybenzamine, Prazosin is a **selective, competitive alpha-1 blocker**. It binds reversibly to the receptor, meaning its inhibitory effect can be overcome by increasing the concentration of an agonist (like Noradrenaline). **3. High-Yield Clinical Pearls for NEET-PG:** * **Clinical Use:** Phenoxybenzamine is primarily used in the preoperative management of **Pheochromocytoma** to prevent hypertensive crises. * **The "Epinephrine Reversal" (Dale’s Vasomotor Reversal):** If Epinephrine is given after Phenoxybenzamine, the alpha-mediated vasoconstriction is blocked, leaving the beta-2 mediated vasodilation unopposed, resulting in a **fall** in blood pressure. * **Other Covalent Inhibitors:** Other high-yield examples of covalent/irreversible binding include **Aspirin** (COX enzymes), **Omeprazole** (H+/K+ ATPase), and **Organophosphates** (Acetylcholinesterase).

Q: Sodium and/or potassium ions are involved in the mechanism of action of which of the following receptors?

All of the above. **Explanation:** The correct answer is **All of the above** because all three receptors listed are linked to ion channels (either directly or indirectly) that regulate the flux of sodium ($Na^+$) and/or potassium ($K^+$) ions. 1. **Neuromuscular ($N_m$) and Neuronal ($N_n$) Receptors:** These are **Ionotropic receptors** (Ligand-gated ion channels). When Acetylcholine binds to these nicotinic receptors, it causes the opening of a central pore that is permeable to both $Na^+$ and $K^+$. The rapid influx of $Na^+$ leads to depolarization, which triggers an action potential (muscle contraction in $N_m$ and post-ganglionic firing in $N_n$). 2. **Dopamine Receptors:** These are **Metabotropic receptors** (G-Protein Coupled Receptors - GPCRs). While they don't form a channel themselves, their downstream signaling significantly affects ion conductance. For example, $D_2$ receptors are coupled to $G_i/G_o$ proteins, which often lead to the **opening of $K^+$ channels** (causing hyperpolarization) and the **inhibition of $Na^+$ or $Ca^{2+}$ channels**. **Why "All of the above" is correct:** While the mechanism differs (direct gating for Nicotinic vs. indirect modulation for Dopamine), all three receptors fundamentally rely on the movement of $Na^+$ and/or $K^+$ to exert their physiological effects. **High-Yield Clinical Pearls for NEET-PG:** * **Nicotinic Receptors ($N_m, N_n$):** Always excitatory; work via rapid $Na^+$ influx. * **G-Protein Modulation:** $G_i$ coupled receptors (like $D_2, M_2, \alpha_2$) typically increase $K^+$ efflux, leading to membrane stabilization/hyperpolarization. * **Fast vs. Slow:** Ionotropic receptors (Nicotinic) act in milliseconds, whereas Metabotropic (Dopamine) act in seconds to minutes.

Q: Zero order kinetics means

A constant amount of drug is eliminated per unit time. ### Explanation **Zero-order kinetics** (also known as saturation kinetics or non-linear kinetics) occurs when the elimination rate of a drug is independent of its plasma concentration. **1. Why Option A is Correct:** In zero-order kinetics, the metabolic pathways or transport systems responsible for drug elimination become **saturated**. Because the enzymes are working at their maximum capacity ($V_{max}$), they can only process a **fixed, constant amount** of the drug per unit of time (e.g., 10 mg every hour), regardless of how much drug is present in the blood. **2. Why Other Options are Incorrect:** * **Option B:** This describes **First-order kinetics**, where a constant *fraction* or percentage of the drug is eliminated per unit time. This is the most common pattern for most drugs at therapeutic doses, where the rate of elimination is directly proportional to the plasma concentration. * **Option C:** This is the definition of **Bioavailability ($F$)**, which refers to the proportion of an administered dose that reaches the systemic circulation in an unchanged form. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "WAT" Mnemonic:** Common drugs following zero-order kinetics include **W**arfarin (at high doses), **A**lcohol (Ethanol), **A**spirin (at high doses), and **T**heophylline/Phenytoin. * **Half-life ($t_{1/2}$):** Unlike first-order kinetics, the half-life in zero-order kinetics is **not constant**; it decreases as the plasma concentration decreases. * **Graphing:** On a graph of Plasma Concentration vs. Time, zero-order kinetics produces a **straight line**, whereas first-order kinetics produces a curve. * **Clinical Risk:** Drugs following zero-order kinetics are more prone to toxicity because a small increase in dose can lead to a disproportionately large increase in plasma concentration once saturation occurs.

Q: Elimination after 3 half-lives in first-order kinetics is:

87.50%. ### Explanation **1. Understanding the Correct Answer (87.50%)** In **First-Order Kinetics**, a constant *fraction* of the drug is eliminated per unit of time. This means that with every half-life ($t_{1/2}$), the concentration of the drug remaining in the plasma is reduced by exactly 50%. To calculate the amount eliminated, we track the amount **remaining** first: * **After 1 $t_{1/2}$:** 50% remains (50% eliminated). * **After 2 $t_{1/2}$:** 50% of 50% = 25% remains (75% eliminated). * **After 3 $t_{1/2}$:** 50% of 25% = **12.5% remains**. To find the total amount eliminated: $100\% - 12.5\% = \mathbf{87.5\%}$. **2. Analysis of Incorrect Options** * **A. 12.50%:** This represents the amount of drug **remaining** in the body after 3 half-lives, not the amount eliminated. * **B. 75%:** This is the amount eliminated after **2 half-lives**. * **D. 94%:** This is the approximate amount eliminated after **4 half-lives** (specifically 93.75%). **3. NEET-PG High-Yield Pearls** * **Steady State:** It takes approximately **4 to 5 half-lives** to reach steady-state concentration ($C_{ss}$) during constant drug administration, and similarly 4 to 5 half-lives to completely eliminate a drug (>95%) after stopping it. * **First-Order vs. Zero-Order:** Most drugs follow first-order kinetics. In **Zero-Order kinetics** (e.g., Ethanol, high-dose Aspirin, Phenytoin), a constant *amount* (not fraction) is eliminated, and the concept of a fixed half-life does not apply. * **Formula for Half-life:** $t_{1/2} = 0.693 \times V_d / CL$. Note that half-life is independent of the dose in first-order kinetics.

Q: What percentage of a drug remains in the body after 3 half-lives?

12.50%. ### Explanation **Concept: First-Order Kinetics and Half-Life ($t_{1/2}$)** Most drugs follow first-order kinetics, where a constant **fraction** of the drug is eliminated per unit of time. The half-life is the time required for the plasma concentration of a drug to reduce by 50%. To calculate the percentage of drug remaining after $n$ half-lives, use the formula: **Remaining % = $(1/2)^n \times 100$** * **After 1 half-life:** $100\% \div 2 = 50\%$ remains. * **After 2 half-lives:** $50\% \div 2 = 25\%$ remains. * **After 3 half-lives:** $25\% \div 2 = \mathbf{12.5\%}$ **remains.** (Correct Answer) --- ### Analysis of Options * **Option A (12.50%):** Correct. As calculated above, after three cycles of 50% reduction, 12.5% of the original dose is still present in the systemic circulation. * **Option B (75%):** Incorrect. This represents the amount of drug **eliminated** after 2 half-lives ($100\% - 25\%$). * **Option C (87.50%):** Incorrect. This is the amount of drug **eliminated** after 3 half-lives ($100\% - 12.5\%$). * **Option D (94%):** Incorrect. This is approximately the amount of drug **eliminated** after 4 half-lives (93.75%). --- ### High-Yield NEET-PG Pearls 1. **Steady State:** It takes **4 to 5 half-lives** for a drug to reach steady-state concentration ($C_{ss}$) during constant infusion, and similarly, 4 to 5 half-lives for a drug to be considered "completely" eliminated from the body. 2. **Fixed Fraction vs. Fixed Amount:** In first-order kinetics, a **constant fraction** is eliminated. In zero-order kinetics (e.g., high-dose Aspirin, Alcohol, Phenytoin), a **constant amount** is eliminated regardless of plasma concentration. 3. **Rule of 7:** After 7 half-lives, more than 99% of the drug is eliminated.

Q: Rate of elimination of a new drug is 20 mg/hr at a steady state plasma concentration of 10 mg/L, then its renal clearance will be?

2.0 L/hr. Explanation 1. Understanding the Correct Answer (Option B: 2.0 L/hr) The core concept here is the relationship between the Rate of Elimination , Clearance (CL) , and Plasma Concentration (Cp) . Clearance is defined as the volume of plasma from which a drug is completely removed per unit of time. The mathematical formula is: $\text{Clearance (CL)} = \frac{\text{Rate of Elimination}}{\text{Plasma Concentration (Cp)}}$ [1] Plugging in the values from the question: * Rate of Elimination = 20 mg/hr * Plasma Concentration = 10 mg/L * $CL = \frac{20 \text{ mg/hr}}{10 \text{ mg/L}} = \mathbf{2.0 \text{ L/hr}}$ 2. Why Other Options are Incorrect * Option A (0.5 L/hr): This is the result of dividing concentration by the rate (10/20), which is the inverse of the correct formula. * Option C (5.0 L/hr): This value does not correlate with the provided data and suggests a calculation error. * Option D (20 L/hr): This assumes the clearance is equal to the rate of elimination, ignoring the plasma concentration factor. 3. Clinical Pearls & High-Yield Facts for NEET-PG * First-Order Kinetics: Most drugs follow first-order kinetics, where clearance remains constant regardless of the plasma concentration [1, 4]. * Zero-Order Kinetics: For drugs like Phenytoin, Alcohol, and Aspirin (at high doses), the rate of elimination is constant, but clearance decreases as plasma concentration increases (Saturation kinetics) [1, 4]. * Steady State: At steady state, the Rate of Drug Administration (Maintenance Dose) equals the Rate of Elimination. * Formula Shortcut: Remember that $Maintenance Dose = CL \times Cp_{ss}$. This is a frequent calculation target in NEET-PG.

Q: A 40-year-old man was brought to the ER after ingesting an unknown quantity of phenobarbital, the plasma level of which was 50 mg/L on admission. Pharmacokinetic parameters for phenobarbital are: Vd=40 L, CL=6 L/day, half-life = 4 days, oral bioavailability f=1. What was the approximate quantity of the drug that the patient ingested?

2 g. ### Explanation **1. Why the Correct Answer is Right (The Underlying Concept)** The question asks for the total quantity of the drug in the body (the loading dose or total body load) at the time of admission. This is calculated using the fundamental pharmacokinetic relationship between **Volume of Distribution ($V_d$)**, **Plasma Concentration ($C$)**, and **Amount of Drug ($Q$)**: $$\text{Amount of Drug (Q)} = V_d \times \text{Plasma Concentration (C)}$$ **Calculation:** * Given $V_d = 40\text{ L}$ * Given Plasma Concentration ($C$) = $50\text{ mg/L}$ * $Q = 40\text{ L} \times 50\text{ mg/L} = 2000\text{ mg}$ * $2000\text{ mg} = \mathbf{2\text{ g}}$ Since the oral bioavailability ($f$) is 1 (100%), the amount ingested is equal to the amount in the body. **2. Why Incorrect Options are Wrong** * **Option A (100 mg) & B (500 mg):** These values are significantly lower than the calculated body load. These doses would result in sub-therapeutic plasma levels ($2.5\text{ mg/L}$ and $12.5\text{ mg/L}$ respectively) for a drug with a $40\text{ L}$ $V_d$. * **Option C (1 g):** This would be the answer if the $V_d$ were $20\text{ L}$ or if the plasma concentration were $25\text{ mg/L}$. It represents a mathematical error in applying the formula. **3. Clinical Pearls & High-Yield Facts for NEET-PG** * **Volume of Distribution ($V_d$):** It is a theoretical volume, not a physical one. Drugs with high $V_d$ (e.g., Digoxin, Chloroquine) are sequestered in tissues and cannot be removed effectively by hemodialysis. * **Phenobarbital Management:** It is a weak acid. In toxicity, **urinary alkalinization** (using IV Sodium Bicarbonate) is used to increase its excretion. This process is called "ion trapping." * **Zero-order vs. First-order:** While most drugs follow first-order kinetics (like phenobarbital here), remember **"WATT"** for Zero-order: **W**arfarin (at high doses), **A**lcohol/Aspirin, **T**heophylline, **T**olbutamide, and Phenytoin.

Question 1

An example of covalent drug-receptor interaction is:

Accepted Answer

Phenoxybenzamine binding to alpha adrenergic receptor

Answer

Noradrenaline binding to Beta 1 adrenergic receptor

Answer

Acetylcholine binding to muscarinic receptor

Answer

Prazosin binding to alpha 1 adrenergic receptor

Question 2

Esmolol is a short-acting beta-blocker because:

Accepted Answer

Its plasma hydrolysis by esterases is rapid.

Answer

It has more plasma protein binding.

Answer

It has high lipid solubility.

Answer

It has high oral bioavailability.

Question 3

Sodium and/or potassium ions are involved in the mechanism of action of which of the following receptors?

Accepted Answer

All of the above

Answer

Dopamine receptor

Answer

Neuromuscular (Nm) receptor

Answer

Neuronal (Nn) receptor

Question 4

Zero order kinetics means

Accepted Answer

A constant amount of drug is eliminated per unit time

Answer

A constant fraction of the drug in the body is eliminated per unit time

Answer

The fraction of the administered dose that reaches the systemic circulation

Answer

None of the above

Question 5

Drug X is normally administered at a rate of 50mg/hr. The elimination of Drug X from the body occurs via: Hepatic metabolism 10%, Biliary secretion 10%, Renal excretion 80%. This drug is to be administered to a 65-year-old patient with a GFR of 60 ml/min (assuming normal GFR is 120 ml/min). Liver and biliary functions are normal in the patient. What will be the dose rate of Drug X in this patient?

Accepted Answer

75mg/hr

Answer

50mg/hr

Answer

25mg/hr

Answer

100mg/hr

Question 6

Elimination after 3 half-lives in first-order kinetics is:

Accepted Answer

87.50%

Answer

12.50%

Answer

75%

Answer

94%

Question 7

What percentage of a drug remains in the body after 3 half-lives?

Accepted Answer

12.50%

Answer

75%

Answer

87.50%

Answer

94%

Question 8

Rate of elimination of a new drug is 20 mg/hr at a steady state plasma concentration of 10 mg/L, then its renal clearance will be?

Accepted Answer

2.0 L/hr

Answer

0.5 L/hr

Answer

5.0 L/hr

Answer

20 L/hr

Question 9

A 40-year-old man was brought to the ER after ingesting an unknown quantity of phenobarbital, the plasma level of which was 50 mg/L on admission. Pharmacokinetic parameters for phenobarbital are: Vd=40 L, CL=6 L/day, half-life = 4 days, oral bioavailability f=1. What was the approximate quantity of the drug that the patient ingested?

Accepted Answer

2 g

Answer

100 mg

Answer

500 mg

Answer

1 g

Question 10

Which of the following is true about tachyphylaxis?

Accepted Answer

It involves indirect sympathomimetics.

Answer

It involves direct sympathomimetics.

Answer

Its mechanism is clearly understood.

Answer

Tachyphylaxis of ephedrine is reversed with dopamine.

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?